Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Retained Earnings (2017 - 2025)

Historic Retained Earnings for Selectis Health (GBCS) over the last 13 years, with Q3 2025 value amounting to -$20.4 million.

  • Selectis Health's Retained Earnings fell 417.07% to -$20.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.4 million, marking a year-over-year decrease of 417.07%. This contributed to the annual value of -$20.2 million for FY2024, which is 1378.66% down from last year.
  • Latest data reveals that Selectis Health reported Retained Earnings of -$20.4 million as of Q3 2025, which was down 417.07% from -$21.2 million recorded in Q2 2025.
  • Over the past 5 years, Selectis Health's Retained Earnings peaked at -$8.8 million during Q1 2021, and registered a low of -$21.2 million during Q2 2025.
  • For the 5-year period, Selectis Health's Retained Earnings averaged around -$14.7 million, with its median value being -$13.7 million (2022).
  • In the last 5 years, Selectis Health's Retained Earnings skyrocketed by 2613.88% in 2021 and then tumbled by 9315.65% in 2024.
  • Selectis Health's Retained Earnings (Quarter) stood at -$11.3 million in 2021, then decreased by 21.43% to -$13.7 million in 2022, then decreased by 29.11% to -$17.7 million in 2023, then fell by 13.79% to -$20.2 million in 2024, then decreased by 1.2% to -$20.4 million in 2025.
  • Its last three reported values are -$20.4 million in Q3 2025, -$21.2 million for Q2 2025, and -$20.9 million during Q1 2025.